Helicobacter pylori infection in obesity and its clinical outcome after bariatric surgery

World Journal of Gastroenterology

Volumn 20, Issue 3, 2014, Pages 647-653

  Carabotti, Marilia ^a   D'Ercole, Chiara ^a   Iossa, Angelo ^b   Corazziari, Enrico ^a   Silecchia, Gianfranco ^b   Severi, Carola ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b POLICLINICO UMBERTO I   (Italy)

Author keywords

Antibiotic resistance; Bariatric surgery; Ghrelin; Helicobacter pylori; Obesity

Indexed keywords

CLARITHROMYCIN; GHRELIN; LEPTIN; PEPSINOGEN I; PEPSINOGEN II;

ARTICLE; ATROPHY; BACTERIAL CLEARANCE; BARIATRIC SURGERY; BIOPSY; BODY MASS; DIAGNOSTIC ACCURACY; GASTRITIS; HELICOBACTER INFECTION; HUMAN; IMMUNOASSAY; OBESITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCREENING; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW (TOPIC); UREA BREATH TEST;

ANTIBIOTIC RESISTANCE; BARIATRIC SURGERY; GHRELIN; HELICOBACTER PYLORI; OBESITY;

BARIATRIC SURGERY; BODY MASS INDEX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OBESITY; PREVALENCE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84892862372     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i3.647     Document Type: Article

References (74)

1. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664 [PMID: 22491499 DOI: 10.1136/gutjnl-2012-302084]
2. Iwańczak F, Iwańczak B. Treatment of Helicobacter pylori infection in the aspect of increasing antibiotic resistance. Adv Clin Exp Med 2012; 21: 671-680 [PMID: 23356205]
3. Arslan E, Atilgan H, Yavaşoǧlu I. The prevalence of Helicobacter pylori in obese subjects. Eur J Intern Med 2009; 20: 695-697 [PMID: 19818289 DOI: 10.1016/j.ejim.2009.07.013]
4. Erim T, Cruz-Correa MR, Szomstein S, Velis E, Rosenthal R. Prevalence of Helicobacter pylori seropositivity among patients undergoing bariatric surgery: a preliminary study. World J Surg 2008; 32: 2021-2025 [PMID: 18581170 DOI: 10.1007/s00268-008-9608-7]
5. Nassir R, Qi L, Kosoy R, Garcia L, Allison M, Ochs-Balcom HM, Tylavsky F, Manson JE, Shigeta R, Robbins J, Seldin MF. Relationship between adiposity and admixture in African-American and Hispanic-American women. Int J Obes (Lond) 2012; 36: 304-313 [PMID: 21487399 DOI: 10.1038/ijo.2011.84]
6. Küper MA, Kratt T, Kramer KM, Zdichavsky M, Schneider JH, Glatzle J, Stüker D, Königsrainer A, Brücher BL. Effort, safety, and findings of routine preoperative endoscopic evaluation of morbidly obese patients undergoing bariatric surgery. Surg Endosc 2010; 24: 1996-2001 [PMID: 20135170 DOI: 10.1007/s00464-010-0893-5]
7. Al-Akwaa AM. Prevalence of Helicobacter pylori infection in a group of morbidly obese Saudi patients undergoing bariatric surgery: a preliminary report. Saudi J Gastroenterol 2010; 16: 264-267 [PMID: 20871190 DOI: 10.4103/1319-3767.70610]
8. Dutta SK, Arora M, Kireet A, Bashandy H, Gandsas A. Upper gastrointestinal symptoms and associated disorders in morbidly obese patients: a prospective study. Dig Dis Sci 2009; 54: 1243-1246 [PMID: 18975090 DOI: 10.1007/ s10620-008-0485-6]
9. Verma S, Sharma D, Kanwar P, Sohn W, Mohanty SR, Tortolani AJ, Gorecki P. Prevalence of Helicobacter pylori infection in bariatric patients: a histologic assessment. Surg Obes Relat Dis 2013; 9: 679-685 [PMID: 23246321 DOI: 10.1016/ j.soard.2012.10.001]
10. Zeni TM, Frantzides CT, Mahr C, Denham EW, Meiselman M, Goldberg MJ, Spiess S, Brand RE. Value of preoperative upper endoscopy in patients undergoing laparoscopic gastric bypass. Obes Surg 2006; 16: 142-146 [PMID: 16469214 DOI: 10.1381/09608920677556517]
11. Ramaswamy A, Lin E, Ramshaw BJ, Smith CD. Early effects of Helicobacter pylori infection in patients undergoing bariatric surgery. Arch Surg 2004; 139: 1094-1096 [PMID: 15492150 DOI: 10.1001/archsurg.139.10.1094]
12. Madan AK, Speck KE, Hiler ML. Routine preoperative upper endoscopy for laparoscopic gastric bypass: is it necessary? Am Surg 2004; 70: 684-686 [PMID: 15328800]
13. Hartin CW, ReMine DS, Lucktong TA. Preoperative bariatric screening and treatment of Helicobacter pylori. Surg Endosc 2009; 23: 2531-2534 [PMID: 19444517 DOI: 10.1007/ s00464-009-0449-8]
14. Vanek VW, Catania M, Triveri K, Woodruff RW. Retrospective review of the preoperative biliary and gastrointestinal evaluation for gastric bypass surgery. Surg Obes Relat Dis 2006; 2: 17-22; discussion 22-23 [PMID: 16925307 DOI: 10.1016/j.soard.2005.10.004]
15. Papasavas PK, Gagné DJ, Donnelly PE, Salgado J, Urbandt JE, Burton KK, Caushaj PF. Prevalence of Helicobacter pylori infection and value of preoperative testing and treatment in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis 2008; 4: 383-388 [PMID: 17974495 DOI: 10.1016/j.soard.2007.08.014]
16. Csendes A, Burgos AM, Smok G, Beltran M. Endoscopic and histologic findings of the foregut in 426 patients with morbid obesity. Obes Surg 2007; 17: 28-34 [PMID: 17355765 DOI: 10.1007/s11695-007-9002-9]
17. Dietz J, Ulbrich-Kulcynski JM, Souto KE, Meinhardt NG. Prevalence of upper digestive endoscopy and gastric histopathology findings in morbidly obese patients. Arq Gastroenterol 2012; 49: 52-55 [PMID: 22481686]
18. Maksud FA, Alves JS, Diniz MT, Barbosa AJ. Density of ghrelin-producing cells is higher in the gastric mucosa of morbidly obese patients. Eur J Endocrinol 2011; 165: 57-62 [PMID: 21558140 DOI: 10.1530/EJE-11-0201]
19. Teivelis MP, Faintuch J, Ishida R, Sakai P, Bresser A, Gama-Rodrigues J. Endoscopic and ultrasonographic evaluation before and after Roux-en-Y gastric bypass for morbid obesity. Arq Gastroenterol 2007; 44: 8-13 [PMID: 17639175]
20. Muñoz R, Ibáñez L, Salinas J, Escalona A, Pérez G, Pimentel F, Guzmán S, Boza C. Importance of routine preoperative upper GI endoscopy: why all patients should be evaluated? Obes Surg 2009; 19: 427-431 [PMID: 18795381 DOI: 10.1007/ s11695-008-9673-x]
21. de Moura Almeida A, Cotrim HP, Santos AS, Bitencourt AG, Barbosa DB, Lobo AP, Rios A, Alves E. Preoperative upper gastrointestinal endoscopy in obese patients undergoing bariatric surgery: is it necessary? Surg Obes Relat Dis 2008; 4: 144-149; discussion 144-149 [PMID: 18294926 DOI: 10.1016/ j.soard.2007.12.006]
22. Azagury D, Dumonceau JM, Morel P, Chassot G, Huber O. Preoperative work-up in asymptomatic patients undergoing Roux-en-Y gastric bypass: is endoscopy mandatory? Obes Surg 2006; 16: 1304-1311 [PMID: 17059738 DOI: 10.1381/0960 89206778663896]
23. Kyriazanos ID, Sfiniadakis I, Gizaris V, Hountis P, Hatziveis K, Dafnopoulou A, Datsakis K. The incidence of Helicobacter pylori infection is not increased among obese young individuals in Greece. J Clin Gastroenterol 2002; 34: 541-546 [PMID: 11960066 DOI: 10.1097/01.MCG.0000012493.63127.20]
24. Almazeedi S, Al-Sabah S, Al-Mulla A, Al-Murad A, Al-Mossawi A, Al-Enezi K, Jumaa T, Bastaki W. Gastric histopathologies in patients undergoing laparoscopic sleeve gastrectomies. Obes Surg 2013; 23: 314-319 [PMID: 23184407 DOI: 10.1007/s11695-012-0821-y]
25. Wang HH, Lee WJ, Liew PL, Yang CS, Liang RJ, Wang W, Lin JT, Wu MS. The influence of Helicobacter pylori infection and corpus gastritis on the postoperative outcomes of laparoscopic vertical banded gastroplasty. Obes Surg 2006; 16: 297-307 [PMID: 16545161 DOI: 10.1381/096089206776116417]
26. Liew PL, Lee WJ, Lee YC, Chen WY. Gastric ghrelin expression associated with Helicobacter pylori infection and chronic gastritis in obese patients. Obes Surg 2006; 16: 612-619 [PMID: 16687031 DOI: 10.1381/096089206776945002]
27. Wu MS, Lee WJ, Wang HH, Huang SP, Lin JT. A case-control study of association of Helicobacter pylori infection with morbid obesity in Taiwan. Arch Intern Med 2005; 165: 1552-1555 [PMID: 16009873 DOI: 10.1001/archinte.165.13.1552]
28. Cummings DE. Helicobacter pylori and ghrelin: Interrelated players in body-weight regulation? Am J Med 2004; 117: 436-439 [PMID: 15380502 DOI: 10.1016/j.amjmed.2004.07.034]
29. Nwokolo CU, Freshwater DA, O'Hare P, Randeva HS. Plasma ghrelin following cure of Helicobacter pylori. Gut 2003; 52: 637-640 [PMID: 12692045 DOI: 10.1136/gut.52.5.637]
30. Isomoto H, Ueno H, Saenko VA, Mondal MS, Nishi Y, Kawano N, Ohnita K, Mizuta Y, Ohtsuru A, Yamashita S, Nakazato M, Kohno S. Impact of Helicobacter pylori infection on gastric and plasma ghrelin dynamics in humans. Am J Gastroenterol 2005; 100: 1711-1720 [PMID: 16086706 DOI: 10.1111/j.1572-0241.2005.41492.x]
31. Gokcel A, Gumurdulu Y, Kayaselcuk F, Serin E, Ozer B, Ozsahin AK, Guvener N. Helicobacter pylori has no effect on plasma ghrelin levels. Eur J Endocrinol 2003; 148: 423-426 [PMID: 12656662 DOI: 10.1530/eje.0.1480423]
32. Osawa H, Kita H, Ohnishi H, Nakazato M, Date Y, Bowlus CL, Ishino Y, Watanabe E, Shiiya T, Ueno H, Hoshino H, Satoh K, Sugano K. Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure. J Gastroenterol 2006; 41: 954-961 [PMID: 17096064 DOI: 10.1007/s00535-006-1880-4]
33. Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, Ueno H, Shiiya T, Satoh K, Ishino Y, Sugano K. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 2005; 90: 10-16 [PMID: 15483107 DOI: 10.1210/jc.2004-1330]
34. Méndez-Sánchez N, Pichardo-Bahena R, Vásquez-Fernández F, Lezama-Mora JI, León-Canales AL, Barredo-Prieto B, González-Avila D, Ponciano-Rodríguez G, Uribe M. Effect of Helicobacter pylori infection on gastric ghrelin expression and body weight. Rev Gastroenterol Mex 2007; 72: 359-364 [PMID: 18595324]
35. Tatsuguchi A, Miyake K, Gudis K, Futagami S, Tsukui T, Wada K, Kishida T, Fukuda Y, Sugisaki Y, Sakamoto C. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa. Am J Gastroenterol 2004; 99: 2121-2127 [PMID: 15554990 DOI: 10.1111/j.1572-0241-2004.30291.x]
36. Isomoto H, Nakazato M, Ueno H, Date Y, Nishi Y, Mukae H, Mizuta Y, Ohtsuru A, Yamashita S, Kohno S. Low plasma ghrelin levels in patients with Helicobacter pylori-associated gastritis. Am J Med 2004; 117: 429-432 [PMID: 15380500 DOI: 10.1016/j.amjmed.2004.01.030]
37. Jang EJ, Park SW, Park JS, Park SJ, Hahm KB, Paik SY, Sin MK, Lee ES, Oh SW, Park CY, Baik HW. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. J Gastroenterol Hepatol 2008; 23 Suppl 2: S278-S285 [PMID: 19120912 DOI: 10.1111/j.1440-1746.2008.05415.x]
38. Nweneka CV, Prentice AM. Helicobacter pylori infection and circulating ghrelin levels-a systematic review. BMC Gastroenterol 2011; 11: 7 [PMID: 21269467 DOI: 10.1186/1471-230X-11-7]
39. El-Omar EM, Oien K, El-Nujumi A, Gillen D, Wirz A, Dahill S, Williams C, Ardill JE, McColl KE. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 15-24 [PMID: 9207257 DOI: 10.1016/S0016-508 5.2897.2970075-1]
40. Kekki M, Samloff IM, Varis K, Ihamäki T. Serum pepsinogen I and serum gastrin in the screening of severe atrophic corpus gastritis. Scand J Gastroenterol Suppl 1991; 186: 109-116 [PMID: 1759117 DOI: 10.3109/00365529109103997]
41. Suto H, Yamazaki Y, Yoshida I, Yamakawa A, Ohtani M, Ito Y, Kuriyama M, Kato T, Azuma T. The effects of Helicobacter pylori eradication on body mass index and dyspeptic symptoms. Digestion 2009; 79: 235-242 [PMID: 19401613 DOI: 10.1159/000215386]
42. Torisu T, Matsumoto T, Takata Y, Ansai T, Soh I, Awano S, Nakamichi I, Kagiyama S, Sonoki K, Yoshida A, Hamasaki T, Iida M, Takehara T. Atrophic gastritis, but not antibody to Helicobacter pylori, is associated with body mass index in a Japanese population. J Gastroenterol 2008; 43: 762-766 [PMID: 18958544 DOI: 10.1007/s00535-008-2219-0]
43. Ando T, Mizuno S, Ishida T, Kondo Y, Miki I, Yoshida M, Azuma T, Ishikawa T, Takagi T, Yagi N, Kokura S, Naito Y, Yoshikawa T, Asakawa A, Inui A. Plasma ghrelin isoforms and gastric ghrelin O-acyltransferase expression are influenced by Helicobacter pylori status. Nutrition 2012; 28: 967-972 [PMID: 22483414 DOI: 10.1016/j.nut.2011.11.023]
44. Lane JA, Murray LJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Aliment Pharmacol Ther 2011; 33: 922-929 [PMID: 21366634 DOI: 10.1111/ j.1365-2036.2011.04610.x]
45. Fujiwara Y, Higuchi K, Arafa UA, Uchida T, Tominaga K, Watanabe T, Arakawa T. Long-term effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease. Hepatogastroenterology 2002; 49: 1298-1302 [PMID: 12239930]
46. Yang YJ, Sheu BS, Yang HB, Lu CC, Chuang CC. Eradication of Helicobacter pylori increases childhood growth and serum acylated ghrelin levels. World J Gastroenterol 2012; 18: 2674-2681 [PMID: 22690077 DOI: 10.3748/wjg.v18.i21.2674]
47. Kawano S, Kawahara A, Nakai R, Fu HY, Tsuji S, Tsujii M. Helicobacter pylori infection does not affect serum leptin concentration and body mass index (BMI) in asymptomatic subjects. J Gastroenterol 2001; 36: 579-580 [PMID: 11519840 DOI: 10.1007/s005350170064]
48. Danesh J, Peto R. Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 1998; 316: 1130-1132 [PMID: 9552950 DOI: 10.1136/ bmj.316.7138.1130]
49. Osawa H. Ghrelin and Helicobacter pylori infection. World J Gastroenterol 2008; 14: 6327-6333 [PMID: 19009647 DOI: 10.3748/wjg.14.6327]
50. Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) 2013; 21 Suppl 1: S1-27 [PMID: 23529939 DOI: 10.1002/oby.20461]
51. Sauerland S, Angrisani L, Belachew M, Chevallier JM, Favretti F, Finer N, Fingerhut A, Garcia Caballero M, Guisado Macias JA, Mittermair R, Morino M, Msika S, Rubino F, Tacchino R, Weiner R, Neugebauer EA. Obesity surgery: evidence-based guidelines of the European Association for Endoscopic Surgery (EAES). Surg Endosc 2005; 19: 200-221 [PMID: 15580436 DOI: 10.1007/s00464-004-9194-1]
52. Schirmer B, Erenoglu C, Miller A. Flexible endoscopy in the management of patients undergoing Roux-en-Y gastric bypass. Obes Surg 2002; 12: 634-638 [PMID: 12448383 DOI: 10.1381/096089202321019594]
53. Verset D, Houben JJ, Gay F, Elcheroth J, Bourgeois V, Van Gossum A. The place of upper gastrointestinal tract endoscopy before and after vertical banded gastroplasty for morbid obesity. Dig Dis Sci 1997; 42: 2333-2337 [PMID: 9398814]
54. Koppman JS, Poggi L, Szomstein S, Ukleja A, Botoman A, Rosenthal R. Esophageal motility disorders in the morbidly obese population. Surg Endosc 2007; 21: 761-764 [PMID: 17285388 DOI: 10.1007/s00464-006-9102-y]
55. Peterson HR, Rothschild M, Weinberg CR, Fell RD, McLeish KR, Pfeifer MA. Body fat and the activity of the autonomic nervous system. N Engl J Med 1988; 318: 1077-1083 [PMID: 3352710 DOI: 10.1056/NEJM198804283181701]
56. Hong D, Kamath M, Wang S, Tabet J, Tougas G, Anvari M. Assessment of the afferent vagal nerve in patients with gastroesophageal reflux. Surg Endosc 2002; 16: 1042-1045 [PMID: 12165819 DOI: 10.1007/s00464-001-8322-4]
57. Abdullahi M, Annibale B, Capoccia D, Tari R, Lahner E, Osborn J, Leonetti F, Severi C. The eradication of Helicobacter pylori is affected by body mass index (BMI). Obes Surg 2008; 18: 1450-1454 [PMID: 18443890 DOI: 10.1007/s11695-008-9477-z]
58. Maddox A, Horowitz M, Wishart J, Collins P. Gastric and oesophageal emptying in obesity. Scand J Gastroenterol 1989; 24: 593-598 [PMID: 2762759 DOI: 10.1007/BF00265086]
59. Cheymol G. Effects of obesity on pharmacokinetics implications for drug therapy. Clin Pharmacokinet 2000; 39: 215-231 [PMID: 11020136 DOI: 10.2165/00003088-200039030-00004]
60. Pai MP, Bearden DT. Antimicrobial dosing considerations in obese adult patients. Pharmacotherapy 2007; 27: 1081-1091 [PMID: 17655508 DOI: 10.1592/phco.27.8.1081]
61. Zullo A, Severi C, Vannella L, Hassan C, Sbrozzi-Vanni A, Annibale B. Role of gastritis pattern on Helicobacter pylori eradication. Intern Emerg Med 2012; 7: 517-522 [PMID: 22105372 DOI: 10.1007/s11739-011-0730-4]
62. Cerqueira RM, Manso MC, Correia MR, Fernandes CD, Vilar H, Nora M, Martins P. Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery--fourteen days superior to seven days? Obes Surg 2011; 21: 1377-1381 [PMID: 20838918 DOI: 10.1007/s11695-010-0254-4]
63. Rasmussen JJ, Fuller W, Ali MR. Marginal ulceration after laparoscopic gastric bypass: an analysis of predisposing factors in 260 patients. Surg Endosc 2007; 21: 1090-1094 [PMID: 17514403 DOI: 10.1007/s00464-007-9285-x]
64. Yang CS, Lee WJ, Wang HH, Huang SP, Lin JT, Wu MS. The influence of Helicobacter pylori infection on the development of gastric ulcer in symptomatic patients after bariatric surgery. Obes Surg 2006; 16: 735-739 [PMID: 16756734 DOI: 10.1381/096089206777346754]
65. Loewen M, Giovanni J, Barba C. Screening endoscopy before bariatric surgery: a series of 448 patients. Surg Obes Relat Dis 2008; 4: 709-712 [PMID: 18514584 DOI: 10.1016/ j.soard.2008.02.009]
66. Albawardi A, Almarzooqi S, Torab FC. Helicobacter pylori in sleeve gastrectomies: prevalence and rate of complications. Int J Clin Exp Med 2013; 6: 140-143 [PMID: 23386918]
67. Rawlins L, Rawlins MP, Brown CC, Schumacher DL. Effect of Helicobacter pylori on marginal ulcer and stomal stenosis after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2013; 9: 760-764 [PMID: 22951079 DOI: 10.1016/j.soard.2012.06.012]
68. Keren D, Matter I, Rainis T, Goldstein O, Stermer E, Lavy A. Sleeve gastrectomy leads to Helicobacter pylori eradication. Obes Surg 2009; 19: 751-756 [PMID: 18830786 DOI: 10.1007/ s11695-008-9694-5]
69. Scheffel O, Daskalakis M, Weiner RA. Two important criteria for reducing the risk of postoperative ulcers at the gastrojejunostomy site after gastric bypass: patient compliance and type of gastric bypass. Obes Facts 2011; 4 Suppl 1: 39-41 [PMID: 22027289 DOI: 10.1159/000327340]
70. Moayyedi P, Soo S, Deeks J, Forman D, Mason J, Innes M, Delaney B. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ 2000; 321: 659-664 [PMID: 10987767 DOI: 10.1136/bmj.321.7262.659]
71. Carabotti M, Silecchia G, Greco F, Leonetti F, Piretta L, Rengo M, Rizzello M, Osborn J, Corazziari E, Severi C. Impact of laparoscopic sleeve gastrectomy on upper gastrointestinal symptoms. Obes Surg 2013; 23: 1551-1557 [PMID: 23636996 DOI: 10.1007/s11695-013-0973-4]
72. Eslick GD, Lim LL, Byles JE, Xia HH, Talley NJ. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999; 94: 2373-2379 [PMID: 10483994 DOI: 10.1111/j.1572-0241.1999.01360.x]
73. Scozzari G, Trapani R, Toppino M, Morino M. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis 2013; 9: 133-142 [PMID: 23265766 DOI: 10.1016/j.soard.2012.10.002]
74. Ericksen RE, Rose S, Westphalen CB, Shibata W, Muthupalani S, Tailor Y, Friedman RA, Han W, Fox JG, Ferrante AW Jr, Wang TC. Obesity accelerates Helicobacter felisinduced gastric carcinogenesis by enhancing immature myeloid cell trafficking and TH17 response. Gut 2013; Epub ahead of print [PMID: 23729675]